Skip to main content
Premium Trial:

Request an Annual Quote

Akoya Biosciences: Niro Ramachandran, Gavin Gordon

Akoya Biosciences has appointed Niro Ramachandran as its chief business officer and Gavin Gordon as VP of clinical market development.

Ramachandran previously served as VP of NanoString's spatial biology business unit. Prior to NanoString, he held the role of R&D manager at Life Technologies (now part of Thermo Fisher Scientific). In addition, he cofounded and served as chief technology officer of Auguron.

Prior to Akoya, Gordon held senior level positions at Fluidigm and Thermo Fisher Scientific. He has also served as assistant professor at Harvard Medical School and as a faculty member of Brigham and Women's Hospital and Dana-Farber/Harvard Cancer Center.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.